Hollings Renton - Net Worth and Insider Trading

Hollings Renton Net Worth

The estimated net worth of Hollings Renton is at least $834,320 dollars as of 2024-11-10. Hollings Renton is the Director of Cepheid and owns about 9,517 shares of Cepheid (CPHD) stock worth over $503,925. Hollings Renton is the Director of Portola Pharmaceuticals Inc and owns about 16,020 shares of Portola Pharmaceuticals Inc (PTLA) stock worth over $288,841. Hollings Renton is also the Director of AnaptysBio Inc and owns about 1,950 shares of AnaptysBio Inc (ANAB) stock worth over $41,555. Details can be seen in Hollings Renton's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hollings Renton has not made any transactions after 2024-07-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Hollings Renton

Hollings Renton Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hollings Renton owns 6 companies in total, including Portola Pharmaceuticals Inc (PTLA) , Zymeworks Inc (ZYME) , and AnaptysBio Inc (ANAB) among others .

Click here to see the complete history of Hollings Renton’s form 4 insider trades.

Insider Ownership Summary of Hollings Renton

Ticker	Comapny	Transaction Date	Type of Owner
PTLA	Portola Pharmaceuticals Inc	2020-07-02	director
ZYME	Zymeworks Inc	2022-12-21	director
ANAB	AnaptysBio Inc	2024-07-15	director
		2016-11-04	director
		2004-01-12	director
		2012-06-13	director

Hollings Renton Latest Holdings Summary

Hollings Renton currently owns a total of 3 stocks. Among these stocks, Hollings Renton owns 9,517 shares of Cepheid (CPHD) as of November 7, 2014, with a value of $503,925 and a weighting of 60.4%. Hollings Renton owns 16,020 shares of Portola Pharmaceuticals Inc (PTLA) as of November 1, 2019, with a value of $288,841 and a weighting of 34.62%. Hollings Renton also owns 1,950 shares of AnaptysBio Inc (ANAB) as of July 15, 2024, with a value of $41,555 and a weighting of 4.98%.

Latest Holdings of Hollings Renton

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
CPHD	Cepheid	2014-11-07	9,517	52.95	503,925
PTLA	Portola Pharmaceuticals Inc	2019-11-01	16,020	18.03	288,841
ANAB	AnaptysBio Inc	2024-07-15	1,950	21.31	41,555

Holding Weightings of Hollings Renton

Hollings Renton Form 4 Trading Tracker

According to the SEC Form 4 filings, Hollings Renton has made a total of 0 transactions in Cepheid (CPHD) over the past 5 years. The most-recent trade in Cepheid is the sale of 9,375 shares on November 7, 2014, which brought Hollings Renton around $478,781.

According to the SEC Form 4 filings, Hollings Renton has made a total of 0 transactions in Portola Pharmaceuticals Inc (PTLA) over the past 5 years. The most-recent trade in Portola Pharmaceuticals Inc is the sale of 5,000 shares on November 1, 2019, which brought Hollings Renton around $150,000.

According to the SEC Form 4 filings, Hollings Renton has made a total of 2 transactions in AnaptysBio Inc (ANAB) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in AnaptysBio Inc is the sale of 10,000 shares on July 15, 2024, which brought Hollings Renton around $306,400.

Insider Trading History of Hollings Renton

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Hollings Renton Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Hollings Renton Ownership Network

Ownership Network List of Hollings Renton

No Data

Ownership Network Relation of Hollings Renton

Hollings Renton Owned Company Details

What does Portola Pharmaceuticals Inc do?

Who are the key executives at Portola Pharmaceuticals Inc?

Hollings Renton is the director of Portola Pharmaceuticals Inc. Other key executives at Portola Pharmaceuticals Inc include EVP & General Counsel John B Moriarty , EVP and CFO Mardi Dier , and EVP & CMO Rajiv Patni .

Portola Pharmaceuticals Inc (PTLA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Portola Pharmaceuticals Inc (PTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Portola Pharmaceuticals Inc (PTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Portola Pharmaceuticals Inc (PTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Portola Pharmaceuticals Inc Insider Transactions

No Available Data

What does Zymeworks Inc do?

Who are the key executives at Zymeworks Inc?

Hollings Renton is the director of Zymeworks Inc. Other key executives at Zymeworks Inc include director & Chair & CEO Kenneth Galbraith , SVP & Chief Financial Officer Christopher Astle , and Chief Scientific Officer Paul Andrew Moore .

Zymeworks Inc (ZYME) Insider Trades Summary

Over the past 18 months, Hollings Renton made no insider transaction in Zymeworks Inc (ZYME). Other recent insider transactions involving Zymeworks Inc (ZYME) include a net sale of 6,880 shares made by Christopher Astle , a net purchase of 3,350,000 shares made by Ecor1 Capital, Llc , and a net sale of 23,904 shares made by Kenneth Galbraith .

In summary, during the past 3 months, insiders sold 0 shares of Zymeworks Inc (ZYME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 40,583 shares of Zymeworks Inc (ZYME) were sold and 3,350,000 shares were bought by its insiders, resulting in a net purchase of 3,309,417 shares.

Zymeworks Inc (ZYME)'s detailed insider trading history can be found in Insider Trading Tracker table.

Zymeworks Inc Insider Transactions

No Available Data

What does AnaptysBio Inc do?

Who are the key executives at AnaptysBio Inc?

Hollings Renton is the director of AnaptysBio Inc. Other key executives at AnaptysBio Inc include Chief Medical Officer Paul F. Lizzul , General Counsel Eric J Loumeau , and Chief Financial Officer Dennis Mulroy .

AnaptysBio Inc (ANAB) Insider Trades Summary

Over the past 18 months, Hollings Renton made 2 insider transaction in AnaptysBio Inc (ANAB) with a net sale of 11,950. Other recent insider transactions involving AnaptysBio Inc (ANAB) include a net sale of 11,879 shares made by Paul F. Lizzul , a net sale of 26,687 shares made by Eric J Loumeau , and a net sale of 24,965 shares made by Dennis Mulroy .

In summary, during the past 3 months, insiders sold 30,440 shares of AnaptysBio Inc (ANAB) in total and bought 273,972 shares, with a net purchase of 243,532 shares. During the past 18 months, 233,237 shares of AnaptysBio Inc (ANAB) were sold and 273,972 shares were bought by its insiders, resulting in a net purchase of 40,735 shares.

AnaptysBio Inc (ANAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

AnaptysBio Inc Insider Transactions

No Available Data

What does Cepheid do?

Who are the key executives at Cepheid?

Hollings Renton is the director of Cepheid. Other key executives at Cepheid include director & Chairman of the Board and CEO John L Bishop , EVP & Global Ops & Engineering Marc Haugen , and EVP & Chief Financial Officer Ilan Daskal .

Cepheid (CPHD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cepheid (CPHD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cepheid (CPHD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cepheid (CPHD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cepheid Insider Transactions

No Available Data

What does Rigel Pharmaceuticals Inc do?

Who are the key executives at Rigel Pharmaceuticals Inc?

Hollings Renton is the director of Rigel Pharmaceuticals Inc. Other key executives at Rigel Pharmaceuticals Inc include EVP & Chief Financial Officer Dean L Schorno , Sr VP of Bus Dev and Com Ops Raul R Rodriguez , and EVP & Chief Commercial Officer David A Santos .

Rigel Pharmaceuticals Inc (RIGL) Insider Trades Summary

Over the past 18 months, Hollings Renton made no insider transaction in Rigel Pharmaceuticals Inc (RIGL). Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 52,894 shares made by Raul R Rodriguez , a net sale of 14,519 shares made by David A Santos , and a net sale of 12,628 shares made by Dean L Schorno .

In summary, during the past 3 months, insiders sold 0 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,004 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 8,004 shares.

Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rigel Pharmaceuticals Inc Insider Transactions

No Available Data

What does Affymax Inc do?

Who are the key executives at Affymax Inc?

Hollings Renton is the director of Affymax Inc. Other key executives at Affymax Inc include Chief Financial Officer Mark G Thompson , Chief Commercial Officer Jeffrey H Knapp , and Chief Financial Officer Herb Cross .

Affymax Inc (AFFY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Affymax Inc (AFFY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Affymax Inc (AFFY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Affymax Inc (AFFY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Affymax Inc Insider Transactions

No Available Data

Hollings Renton Mailing Address

Above is the net worth, insider trading, and ownership report for Hollings Renton. Currently GuruFocus does not have mailing address information for Hollings Renton.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.